Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin for Prevention of Postoperative Urinary Retention in Inguinal Hernia Repair
NCT02958878Phase 4Completed
- Sponsor
- Ascension
- Start
- Jan 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in postoperative urinary retention (POUR) comparing Tamsulosin with Placebo (2 arms). Primary endpoint: Number of Urinary Retention at 72 hours. Started Jan 2017; status: completed.
02
Drugs
tamsulosin
03
Conditions
postoperative urinary retention (POUR)
Beyond the preview
Go deeper on NCT02958878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02958878.